Management of immune checkpoint inhibitor‐related rheumatic adverse events-Reference-Cited by-同舟云学术

Management of immune checkpoint inhibitor‐related rheumatic adverse events

Published:2019-11-24 Issue:1 Volume:11 Page:198-202
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Zhou Jiaxin¹^ORCID,Wang Hanping²^ORCID,Guo Xiaoxiao³^ORCID,Wang Qian¹,Duan Lian⁴,Si Xiaoyan²^ORCID,Zhang Li⁵,Liu Xiaowei⁶,Li Yue⁷,Zhang Wen¹,Zhang Li²

Affiliation:

1. Department of RheumatologyPeking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing China

2. Department of Respiratory and Critical Care MedicinePeking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing China

3. Department of CardiologyPeking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing China

4. Department of EndocrinologyPeking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China

5. Department of Clinical LaboratoryPeking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China

6. Department of OphthalmologyPeking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China

7. Department of GastroenterologyPeking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13249

Reference35 articles.

1. Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature

2. Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations

3. Immune Checkpoint Blockade in Cancer Therapy

5. Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors;Cancers;2023-08-07

2. Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody;BMC Cancer;2020-07-14